Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (2)

Search Parameters:
Authors = Sergey Pimanov

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
8 pages, 6807 KiB  
Brief Report
A Bunch of YBCO Josephson Generators for the Analysis of Resonant Cold-Electron Bolometers
by Leonid S. Revin, Dmitry V. Masterov, Alexey E. Parafin, Sergey A. Pavlov, Dmitry A. Pimanov, Alexander V. Chiginev, Anton V. Blagodatkin, Igor V. Rakut’, Evgenii V. Skorokhodov, Anna V. Gordeeva and Andrey L. Pankratov
Appl. Sci. 2022, 12(23), 11960; https://doi.org/10.3390/app122311960 - 23 Nov 2022
Cited by 5 | Viewed by 1639
Abstract
The resonant properties of Cold-Electron Bolometers (CEBs) located at a 0.3 K cryostat plate are measured using a 50 μm long high-temperature YBa2Cu3O7δ (YBCO) Josephson junction oscillator, placed on a 2.7 K plate of the same [...] Read more.
The resonant properties of Cold-Electron Bolometers (CEBs) located at a 0.3 K cryostat plate are measured using a 50 μm long high-temperature YBa2Cu3O7δ (YBCO) Josephson junction oscillator, placed on a 2.7 K plate of the same cryostat. For these purposes, a bunch of YBCO Josephson oscillators with various lengths of dipole antennas and overlapping generation bands has been developed and investigated in 50–500 GHz frequency range. Two setups of Josephson junction placement were compared, and as a result, various narrow-band receiving systems with CEBs have been measured, demonstrating the feasibility of the presented approach. Full article
(This article belongs to the Special Issue Applications of Terahertz Sensing and Imaging)
Show Figures

Figure 1

6 pages, 642 KiB  
Article
Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy
by Marcis Leja, Sanita Lapina, Inese Polaka, Dace Rudzite, Ilona Vilkoite, Ilva Daugule, Anna Belkovets, Sergey Pimanov, Jelena Makarenko, Ivars Tolmanis, Aivars Lejnieks, Viesturs Boka, Ingrida Rumba-Rozenfelde and Uldis Vikmanis
Medicina 2014, 50(1), 8-13; https://doi.org/10.1016/j.medici.2014.05.001 - 5 Jun 2014
Cited by 13 | Viewed by 1083
Abstract
Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. The [...] Read more.
Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. The aim of our study was to evaluate the potential role of pepsinogens I and II, gastrin-17 and H. pylori antibodies in confirming successful eradication.
Material and methods: Altogether 42 patients (25 women, 17 men), mean age 45 years (range 23–74), were enrolled. Pepsinogens I and II, gastrin-17 and H. pylori IgG antibodies were measured in plasma samples using an ELISA test (Biohit, Oyj., Finland) before the eradication and 4 weeks after completing the treatment. The success of eradication was determined by a urea breath test.
Results: Eradication was successful in 31 patients (74%) and unsuccessful in 11 patients (26%). Pepsinogen II decreased significantly in both the successful (P = 0.029) and unsuccessful (P = 0.042) eradication groups. Pepsinogen I decreased significantly in the successful (P = 0.025) but not the unsuccessful (P = 0.29) eradication group. The pepsinogen I/II ratio increased in the successful eradication group (P = 0.0018) but not in the group in which treatment failed (P = 0.12). There were no differences in gastrin-17 or H. pylori antibody values.
Conclusions: A decrease in pepsinogen II levels cannot be used as a reliable marker for the successful eradication of H. pylori 4 weeks after the completion of treatment. The increase in pepsinogen I/II ratio reflects differences in pepsinogen production following the eradication irrespective of improvement in atrophy.
Full article
Back to TopTop